SL Global PCC - Cell B-2 is a private investment fund based in Ebene, Mauritius. According to its most recent Form D, filed Nov 12, 2019, it has sold $250,045 of interests to 4 investors since its first sale in Oct 2019. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Gumtree Capital Advisors LLP; Poovazhagan Soobramanien; Manogaran Thamothiram.
- Total raised
- $250,045Cumulative sales reported on Form D
- Investors
- 4
- First sale
- Oct 4, 2019
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Gumtree Capital Advisors LLP; Poovazhagan Soobramanien; Manogaran Thamothiram
- Latest Form D
- Nov 12, 2019
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about SL Global PCC - Cell B-2
What is the minimum investment for SL Global PCC - Cell B-2?
SL Global PCC - Cell B-2's latest Form D, filed Nov 12, 2019, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in SL Global PCC - Cell B-2?
SL Global PCC - Cell B-2 is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has SL Global PCC - Cell B-2 raised?
SL Global PCC - Cell B-2 reports $250,045 sold from 4 investors on its Form D filed Nov 12, 2019. This is cumulative sales since the offering began, not current assets or performance.
Where is SL Global PCC - Cell B-2 based?
SL Global PCC - Cell B-2 is based in Ebene, Mauritius.
When did SL Global PCC - Cell B-2 launch?
SL Global PCC - Cell B-2 reports its first sale in Oct 2019.
Size compared with every private investment fund
Raised more than 24% of the 21 private investment funds based in Mauritius, and more than 5% of all 10,266 that report sales.